IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

The activation of pro-inflammatory gene programs by nuclear factor-kappaB (NF-kappaB) is primarily regulated through cytoplasmic sequestration of NF-kappaB by the inhibitor of kappaB (IkappaB) family of proteins. IkappaBbeta, a major isoform of IkappaB, can sequester NF-kappaB in the cytoplasm, although its biological role remains unclear. Although cells lacking IkappaBbeta have been reported, in vivo studies have been limited and suggested redundancy between IkappaBalpha and IkappaBbeta. Like IkappaBalpha, IkappaBbeta is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus. The crystal structure of IkappaBbeta bound to p65 suggested this complex might bind DNA. In vitro, hypophosphorylated IkappaBbeta can bind DNA with p65 and c-Rel, and the DNA-bound NF-kappaB:IkappaBbeta complexes are resistant to IkappaBalpha, suggesting hypophosphorylated, nuclear IkappaBbeta may prolong the expression of certain genes. Here we report that in vivo IkappaBbeta serves both to inhibit and facilitate the inflammatory response. IkappaBbeta degradation releases NF-kappaB dimers which upregulate pro-inflammatory target genes such as tumour necrosis factor-alpha (TNF-alpha). Surprisingly, absence of IkappaBbeta results in a dramatic reduction of TNF-alpha in response to LPS even though activation of NF-kappaB is normal. The inhibition of TNF-alpha messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-IkappaBbeta bound to p65:c-Rel heterodimers at a specific kappaB site on the TNF-alpha promoter. Therefore IkappaBbeta acts through p65:c-Rel dimers to maintain prolonged expression of TNF-alpha. As a result, IkappaBbeta(-/-) mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking IkappaBbeta might be a promising new strategy for selectively inhibiting the chronic phase of TNF-alpha production during the inflammatory response.

[1]  T. McKinsey,et al.  Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product , 1996, Molecular and cellular biology.

[2]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[3]  D. Kwiatkowski,et al.  Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. , 1999, Journal of immunology.

[4]  H. Suyang,et al.  Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB , 1996 .

[5]  H. Erdjument-Bromage,et al.  IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.

[6]  I. Verma,et al.  The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. , 1991, Genes & development.

[7]  A. Israël,et al.  IκBε-Deficient Mice: Reduction of One T Cell Precursor Subspecies and Enhanced Ig Isotype Switching and Cytokine Synthesis , 1999, The Journal of Immunology.

[8]  S. Ghosh,et al.  NF-κB and the immune response , 2006, Oncogene.

[9]  A. Hoffmann,et al.  Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Ghosh,et al.  Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B , 1996, Molecular and cellular biology.

[11]  A. Israël,et al.  IκBα/IκBε deficiency reveals that a critical NF-κB dosage is required for lymphocyte survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. Verma,et al.  Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.

[13]  M. Feldmann,et al.  Development of anti-TNF therapy for rheumatoid arthritis , 2002, Nature Reviews Immunology.

[14]  Jiahuai Han,et al.  Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2] , 1990, The Journal of experimental medicine.

[15]  A. Israël,et al.  Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha. , 1997, The Journal of biological chemistry.

[16]  S. Zuckerman,et al.  Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. , 1989, Circulatory shock.

[17]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[18]  Iain B McInnes,et al.  Evidence that cytokines play a role in rheumatoid arthritis. , 2008, The Journal of clinical investigation.

[19]  C. Stewart,et al.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.

[20]  G. Ghosh,et al.  IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells* , 2001, The Journal of Biological Chemistry.

[21]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[22]  M. Merika,et al.  Distinct functional properties of IkappaB alpha and IkappaB beta , 1997, Molecular and cellular biology.

[23]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[24]  N. Rice,et al.  The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers , 1995, Molecular and cellular biology.

[25]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[26]  S. Ghosh,et al.  X-ray Crystal Structure of an IκBβ·NF-κB p65 Homodimer Complex* , 2003, Journal of Biological Chemistry.

[27]  D. Guttridge,et al.  RelA/p65 Regulation of IκBβ , 2005, Molecular and Cellular Biology.

[28]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[29]  R. Bravo,et al.  Functional Redundancy of the Nuclear Factor κB Inhibitors IκBα and IκBβ , 1998, The Journal of experimental medicine.

[30]  S. Ghosh,et al.  Regulation of IkappaB beta in WEHI 231 mature B cells , 1997, Molecular and cellular biology.

[31]  A. Baldwin,et al.  NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.